In chronic neurodegenerative diseases, MTx has been proposed as a means to counteract the chronic inflammation that contributes to neuronal damage, with the potential to alter the disease course in conditions such as Alzheimer's and Parkinson's disease (PD) [74]. Here, MTX1 is linked to Parkinson disease.